Tharimmune, Inc. (THAR) Financial Statements
Industry: Finance Services
In fiscal 2025, Tharimmune reported revenue of $0. Net income was -$35.9M, or -$1.12 per diluted share. Operating activities generated -$16.1M of cash. At fiscal year end, Tharimmune held $519.1M in total assets against $121.2M in total liabilities.
Open the full interactive Tharimmune financials → Quarterly statements, key ratios, valuation history and price charts.
Tharimmune Key Stats
| Share Price | $2.02 |
|---|---|
| Market Cap | $438.1M |
| 52-Week Range | $1.85 – $5.48 |
| Shares Outstanding | 216.9 million (basic, 2026 Q2) |
Tharimmune Income Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| Operating Income | -$3.2M | -$6.9M | -$9.5M | -$12.4M | -$20.1M |
| Pre-Tax Income | -$2.2M | -$8.5M | -$9.3M | -$12.2M | -$42.1M |
| Income Tax | — | — | $0 | — | -$6.2M |
| Net Income | -$2.2M | -$8.5M | -$9.3M | -$12.2M | -$35.9M |
| Diluted EPS | -$131.25 | — | -$107.10 | -$9.41 | -$1.12 |
Tharimmune Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $1.5M |
| Net Income | -$2.1M | -$29.4M | -$47.3M | -$19.3M |
| Diluted EPS | -$0.34 | -$0.92 | -$0.23 | -$0.09 |
Tharimmune Balance Sheet
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Cash & Equivalents | — | — | $10.9M | — | — |
| Current Assets | $621,677 | $6.7M | $10.9M | $3.7M | $17.4M |
| Total Assets | $621,677 | $6.7M | $10.9M | $3.7M | $519.1M |
| Current Liabilities | $4.5M | $1.1M | $1.8M | $2.4M | $3.3M |
| Total Long-Term Debt | $2.2M | — | — | — | — |
| Total Liabilities | $5.3M | $1.1M | $1.8M | $2.4M | $121.2M |
| Shareholders' Equity | -$4.7M | $5.5M | $9.1M | $1.3M | $397.9M |
Tharimmune Cash Flow Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Cash From Operations | -$1.1M | -$6.6M | -$7.3M | -$10.9M | -$16.1M |
| Cash From Investing | — | — | — | — | -$77.6M |
| Cash From Financing | $898,748 | $13.1M | $11.7M | $3.5M | $107.2M |
| Free Cash Flow | — | -$6.6M | -$7.3M | -$10.9M | — |
Figures from Tharimmune's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Tharimmune financials page for every line item.
Tharimmune Company Profile
| Ticker | THAR |
|---|---|
| Exchange | Nasdaq |
| Industry | Finance Services |
| Headquarters | New York, New York |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Emerging growth company |
| SEC CIK | 0001861657 |
Frequently Asked Questions
What was Tharimmune's revenue in fiscal 2025?
Tharimmune (THAR) reported revenue of $0 for fiscal 2025.
What is Tharimmune's annual revenue history?
Tharimmune's annual revenue by fiscal year: 2021: $0; 2022: $0; 2023: $0; 2024: $0; 2025: $0.
What was Tharimmune's net income in fiscal 2025?
Tharimmune reported net income of -$35.9M for fiscal 2025.
What was Tharimmune's earnings per share (EPS) in fiscal 2025?
Tharimmune's diluted EPS was -$1.12 for fiscal 2025 (adjusted for any later stock splits).
What was Tharimmune's revenue last quarter?
In its most recent reported quarter (2026 Q2), Tharimmune reported revenue of $1.5M.
How many shares of Tharimmune are outstanding?
Tharimmune reported a weighted average of 216.9 million basic shares outstanding in 2026 Q2.
What is Tharimmune's market cap?
Based on its latest closing price, Tharimmune (THAR) has a market capitalization of about $438.1M.
When does Tharimmune's fiscal year end?
Tharimmune's fiscal year end, as registered with the SEC, is December 31.
Where is Tharimmune headquartered?
Tharimmune lists its business address in New York, New York in its SEC filings.